Cargando…
The dog prostate cancer (DPC-1) model: a reliable tool for molecular imaging of prostate tumors and metastases
BACKGROUND: Clinical applicability of newly discovered reagents for molecular imaging is hampered by the lack of translational models. As the dog prostate cancer (DPC-1) model recapitulates in dogs the natural history of prostate cancer in man, we tested the feasibility of single-photon emission com...
Autores principales: | Chevalier, Simone, Moffett, Serge, Turcotte, Eric, Luz, Murillo, Chauvette, Lyne, Derbekyan, Vilma, Scarlata, Eleonora, Zouanat, Fatima, Aprikian, Armen G., Anidjar, Maurice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695479/ https://www.ncbi.nlm.nih.gov/pubmed/26714499 http://dx.doi.org/10.1186/s13550-015-0155-6 |
Ejemplares similares
-
Cell‐by‐cell quantification of the androgen receptor in benign and malignant prostate leads to a better understanding of changes linked to cancer initiation and progression
por: Derderian, Seta, et al.
Publicado: (2023) -
Improving ultrasound-based prostate volume estimation
por: Aprikian, Saro, et al.
Publicado: (2019) -
Nuclear mTOR acts as a transcriptional integrator of the androgen signaling pathway in prostate cancer
por: Audet-Walsh, Étienne, et al.
Publicado: (2017) -
Asporin is a stromally expressed marker associated with prostate cancer progression
por: Rochette, Annie, et al.
Publicado: (2017) -
A preliminary study on the diagnostic value of PSADR, DPC and TSRP in the distinction of prostatitis and prostate cancer
por: He, Minxin, et al.
Publicado: (2022)